Intracranial Stents Market - 2021-2031

November 2025 | 217 pages | ID: I5310FED288AEN
DataM Intelligence

Abstracts

The Intracranial Stents Market was valued at US$ 360 million in 2021 and is anticipated to reach US$ 702.8 million by 2031, at a CAGR of 0.0898 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Intracranial Stents Market.

This report delivers a comprehensive overview of the Intracranial Stents Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Intracranial Stents Market. The Intracranial Stents Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2031.

Intracranial Stents Market Scope:

By Product Type

• Self-expanding stents
• Balloon expanding stents
• Stent-assisted coil embolization

By Disease Indication

• Brain aneurysm
• Intracranial stenosis

By Design

• Open-cell
• Closed-cell

By Uses

• Neuroform
• Solitaire
• Enterprise
• Leo Plus
• Wingspan

By End User

• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Others

Key Players

• Medtronic plc
• Penumbra, Inc
• Stryker Corporation
• Boston Scientific Corporation Inc
• Terumo Corporation
• Cook Medical
• DePuy Synthes
• Balt Extrusion S.A
• MicroPort Scientific Corporation
• Abbott Laboratories

Major Highlights

This report delivers a comprehensive overview of the Intracranial Stents Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Intracranial Stents Market. The Intracranial Stents Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2031.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification

• Increase Your Customer Base by 3X using our Partner Identification tool
• Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
• Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
• Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. MARKET DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Market Snippet by Product Type
3.2. Market Snippet by Disease Indication
3.3. Market Snippet by Design
3.4. Market Snippet by Uses
3.5. Market Snippet by End-User
3.6. Market Snippet by Region

4. MARKET DYNAMICS

4.1. Market Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Rising prevalence of chronic neurological diseases
  4.1.2. Restraint
    4.1.2.1. Risks of complications
  4.1.3. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. PEST Analysis
5.4. Pricing Analysis
5.5. Regulatory Analysis
5.6. Reimbursement Analysis
5.7. Unmet Needs

6. COVID-19 ANALYSIS

6.1. Analysis of Covid-19 on the Market
  6.1.1. Before COVID-19 Market Scenario
  6.1.2. Present COVID-19 Market Scenario
  6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. BY PRODUCT TYPE

7.1. Introduction
  7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
  7.1.2. Market Attractiveness Index, By Product Type Segment
7.2. Self-expanding stents*
  7.2.1. Introduction
  7.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Balloon expanding stents
7.4. Stent-assisted coil embolization

8. BY DISEASE INDICATION

8.1. Introduction
  8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication Segment
  8.1.2. Market Attractiveness Index, By Disease Indication Segment
8.2. Brain aneurysm*
  8.2.1. Introduction
  8.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Intracranial stenosis

9. BY DESIGN

9.1. Introduction
  9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design Segment
  9.1.2. Market Attractiveness Index, By Design Segment
9.2. Open-cell
  9.2.1. Introduction
  9.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Closed-cell

10. BY USES

10.1. Introduction
  10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Uses Segment
  10.1.2. Market Attractiveness Index, By Uses Segment
10.2. Neuroform*
  10.2.1. Introduction
  10.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
10.3. Solitaire
10.4. Enterprise
10.5. Leo Plus
10.6. Wingspan

11. BY END USER

11.1. Introduction
  11.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
  11.1.2. Market Attractiveness Index, By End User Segment
11.2. Hospitals*
  11.2.1. Introduction
  11.2.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
11.3. Ambulatory Surgical Centers
11.4. Clinics
11.5. Others

12. BY REGION

12.1. Introduction
12.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
12.3. Market Attractiveness Index, By Region
12.4. North America
  12.4.1. Introduction
  12.4.2. Key Region-Specific Dynamics
  12.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  12.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
  12.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
  12.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Uses
  12.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  12.4.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    12.4.8.1. US.
    12.4.8.2. Canada
    12.4.8.3. Mexico
12.5. Europe
  12.5.1. Introduction
  12.5.2. Key Region-Specific Dynamics
  12.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  12.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
  12.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
  12.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Uses
  12.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  12.5.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    12.5.8.1. Germany
    12.5.8.2. U.K.
    12.5.8.3. France
    12.5.8.4. Italy
    12.5.8.5. Spain
    12.5.8.6. Rest of Europe
12.6. South America
  12.6.1. Introduction
  12.6.2. Key Region-Specific Dynamics
  12.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  12.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
  12.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
  12.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Uses
  12.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  12.6.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    12.6.8.1. Brazil
    12.6.8.2. Argentina
    12.6.8.3. Rest of South America
12.7. Asia Pacific
  12.7.1. Introduction
  12.7.2. Key Region-Specific Dynamics
  12.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  12.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
  12.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
  12.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Uses
  12.7.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  12.7.8. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    12.7.8.1. China
    12.7.8.2. India
    12.7.8.3. Japan
    12.7.8.4. Australia
    12.7.8.5. Rest of Asia Pacific
12.8. Middle East and Africa
  12.8.1. Introduction
  12.8.2. Key Region-Specific Dynamics
  12.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  12.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Indication
  12.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
  12.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Uses
  12.8.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

13. COMPETITIVE LANDSCAPE

13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis

14. COMPANY PROFILES

14.1. Medtronic plc
  14.1.1. Company Overview
  14.1.2. Product Portfolio and Description
  14.1.3. Key Highlights
  14.1.4. Financial Overview
14.2. Penumbra, Inc
14.3. Stryker Corporation
14.4. Boston Scientific Corporation Inc
14.5. Terumo Corporation
14.6. Cook Medical
14.7. DePuy Synthes
14.8. Balt Extrusion S.A
14.9. MicroPort Scientific Corporation
14.10. Abbott Laboratories (*LIST NOT EXHAUSTIVE)

15. DATAM INTELLIGENCE

15.1. Appendix
15.2. About Us and Services
15.3. Contact Us